Beck Mack & Oliver LLC Merck & Co., Inc. Transaction History

Beck Mack & Oliver LLC

  • $4.25 Billion
  • Q2 2024

A detailed history of Beck Mack & Oliver LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 122,662 shares of MRK stock, worth $12.7 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
122,662
Previous 130,813 6.23%
Holding current value
$12.7 Million
Previous $17.3 Million 12.02%
% of portfolio
0.36%
Previous 0.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$123.8 - $132.96 $1.01 Million - $1.08 Million
-8,151 Reduced 6.23%
122,662 $15.2 Million
Q1 2024

May 14, 2024
SELL
$113.24 - $131.95 $413,099 - $481,353
-3,648 Reduced 2.71%
130,813 $17.3 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $60,007 - $65,302
-599 Reduced 0.44%
134,461 $14.7 Million
Q3 2023

Nov 13, 2023
SELL
$102.95 - $114.33 $193,751 - $215,169
-1,882 Reduced 1.37%
135,060 $13.9 Million
Q2 2023

Aug 08, 2023
SELL
$108.61 - $118.38 $236,552 - $257,831
-2,178 Reduced 1.57%
136,942 $15.8 Million
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $326,834 - $364,680
-3,175 Reduced 2.23%
139,120 $14.8 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $241,946 - $310,208
-2,767 Reduced 1.91%
142,295 $15.8 Million
Q3 2022

Nov 10, 2022
SELL
$84.53 - $94.96 $653,839 - $734,515
-7,735 Reduced 5.06%
145,062 $12.5 Million
Q2 2022

Aug 12, 2022
SELL
$83.49 - $94.64 $1.16 Million - $1.31 Million
-13,893 Reduced 8.33%
152,797 $13.9 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $426,946 - $478,579
-5,808 Reduced 3.37%
166,690 $13.7 Million
Q4 2021

Jan 28, 2022
SELL
$72.28 - $90.54 $37,296 - $46,718
-516 Reduced 0.3%
172,498 $13.2 Million
Q3 2021

Nov 04, 2021
SELL
$71.68 - $78.83 $22,937 - $25,225
-320 Reduced 0.18%
173,014 $13 Million
Q2 2021

Jul 28, 2021
BUY
$70.31 - $77.77 $1.08 Million - $1.2 Million
15,421 Added 9.77%
173,334 $13.5 Million
Q1 2021

May 11, 2021
SELL
$68.86 - $81.11 $1.41 Million - $1.67 Million
-20,531 Reduced 11.51%
157,913 $12.2 Million
Q4 2020

Feb 10, 2021
SELL
$71.77 - $79.65 $339,400 - $376,664
-4,729 Reduced 2.58%
178,444 $14.6 Million
Q3 2020

Nov 02, 2020
SELL
$73.18 - $82.95 $56,641 - $64,203
-774 Reduced 0.42%
183,173 $15.2 Million
Q2 2020

Aug 10, 2020
SELL
$70.42 - $80.13 $767,507 - $873,336
-10,899 Reduced 5.59%
183,947 $14.2 Million
Q1 2020

May 05, 2020
SELL
$63.36 - $87.82 $304,571 - $422,150
-4,807 Reduced 2.41%
194,846 $15 Million
Q4 2019

Feb 07, 2020
SELL
$77.58 - $87.54 $452,989 - $511,146
-5,839 Reduced 2.84%
199,653 $18.2 Million
Q3 2019

Nov 06, 2019
SELL
$76.08 - $82.93 $1.08 Million - $1.17 Million
-14,137 Reduced 6.44%
205,492 $17.3 Million
Q2 2019

Aug 13, 2019
SELL
$69.84 - $81.59 $233,964 - $273,326
-3,350 Reduced 1.5%
219,629 $18.4 Million
Q1 2019

May 02, 2019
SELL
$69.58 - $79.36 $561,649 - $640,593
-8,072 Reduced 3.49%
222,979 $18.5 Million
Q4 2018

Feb 04, 2019
SELL
$65.24 - $75.71 $1.11 Million - $1.29 Million
-17,068 Reduced 6.88%
231,051 $17.7 Million
Q3 2018

Oct 29, 2018
SELL
$57.69 - $67.84 $17.5 Million - $20.6 Million
-303,138 Reduced 54.99%
248,119 $17.6 Million
Q2 2018

Jul 25, 2018
SELL
$50.83 - $59.72 $466,466 - $548,050
-9,177 Reduced 1.64%
551,257 $0
Q1 2018

Apr 25, 2018
SELL
$50.96 - $59.23 $745,901 - $866,949
-14,637 Reduced 2.55%
560,434 $0
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $462,411 - $552,171
-8,958 Reduced 1.53%
575,071 $0
Q3 2017

Oct 27, 2017
BUY
$58.67 - $63.13 $34.3 Million - $36.9 Million
584,029
584,029 $0

Others Institutions Holding MRK

# of Institutions
3,805
Shares Held
1.92B
Call Options Held
13.4M
Put Options Held
10.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $263B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email